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Abstract
Objectives: We examined the prevalence of latex allergy in subjects with occupational exposure to latex allergens for less than 
5 years, determining the disease spectrum in symptomatic workers. We identified the most frequent molecular allergens by Immuno-




common symptom was contact dermatitis (N = 18, 72%). In 12 subjects, ICAP revealed a real sensitization to latex, with a recom-
binant latex allergen profile showing a high frequency for rHev b 6.01 specific immunoglobulin E (sIgE) (N = 9, 67%). In these 
individuals, skin symptoms were more prevalent than other types (88%). Conclusions: The combined positivity for rHev b 6.01,  
rHev 8 and rHev b 5 determined by ICAP identified 92% of latex-allergic subjects with short-term exposure to latex.
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INTRODUCTION
Natural rubber latex (NRL) comes from the sap of 
the tropical tree Hevea brasiliensis. It is an elastic agent 
(polymeric cis-1,4 isoprene) with a proteic component 
of 2–3%. More precisely, 15 latex proteins have been 
identified and characterized [1]. Sometimes it is very diffi-
cult to discern between NRL allergy and an asymptomatic 
state of awareness, on account of the presence of carbo-
hydrate  cross-reacting  determinants  or  profilin.  In  fact, 
many cases of sensitization to latex profilin occurs via pro-
filins of pollen or food origin [2–5].
Allergy to NRL has been an important occupational 
health concern for more than 20 years, particularly among 
healthcare  workers,  because  about  50%  of  medical 
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informed consent from each subject to perform the ex-
amination and to publish the final results [29]. Exclusion 
criteria  were  treatment  with  β-blockers,  antihistamines, 
tricyclic antidepressants or corticosteroids up to 3 weeks 
before  the  study,  and  pregnancy  or  breast  feeding  [30]. 
The  2  types  of  gloves  distributed  and  equally  used  at 
the university’s hospital are powdered latex gloves (Na-
turex 626 Classic, Nacatur, Italy) and non-powdered latex 
gloves (Naturex 626 Salus, Nacatur, Italy).
The  questionnaire  was  given  by  4  trained  interviewers. 
Sociodemographic data were checked to characterize 
the study population and to investigate risk factors, and 
clinical symptoms were recorded. Questions included sex, 
age, frequency of latex glove use, exposure (hours of glove 
use per day up to 3 days before the interview) and infor-
mation on family and personal histories of allergic disor-
ders, exposure to other latex items (household cleaning 
gloves, balloons, diaphragm, condoms), number of times 
a day that hands were washed, and exposure to chemical 






tion appearing at several skin sites. Contact dermatitis was 
defined as a self-reported persistent erythemato-papulous 
eruption appearing on the skin after 2–3 days from con-
tact with latex gloves [33]. Eye and respiratory symptoms 
(burning, stuffy sensations, sneezing or asthmatic symp-
toms) were deemed present if 1 or more symptoms were 
reported at least a few days a week [33].
Only when the questionnaire indicated a possible allergy 
to  latex  was  an  SPT  performed  with  disposable  sterile 
needles on the volar region of the forearm. A commercial 
latex preparation at  a  concentration of  100  IR/ml  (Stal-
lergenes Italia, Milan, Italy) was used as the allergen. His-
tamine (10 mg/ml) was used as a positive control; a sterile 
devices contain latex. The main source of workplace expo-
sure is use of powdered latex gloves by healthcare work-
ers. In studies on hospital personnel, latex sensitivity was 
found to be 3–5 times higher among nurses and doctors 
than among personnel not involved in patient care [6–21]. 
The  prevalence  of  latex  allergy  in  healthcare  settings  is 
reported to be affected by several factors, including ato-
py [21–23], frequency of glove use, prior or current hand 
dermatitis and also the long exposure-times when working 
in hospitals [24–27].
The objectives of this study were: 
 – to examine the prevalence of latex allergy in a group 
of 723 subjects with less than 5 years of occupational 
exposure to latex;
 – to determine the disease spectrum in symptomatic 
workers who met the inclusion criteria;
 – to  identify  the most  frequent molecular  allergens  for 
the diagnosis of genuine latex allergy in this sympto-
matic group by ImmunoCAP (ICAP) and to correlate 
these results with skin prick tests (SPT).
In fact, ICAP is becoming a viable alternative to other 
in vivo tests because it has increased diagnostic accuracy 
for latex allergy and can be used in those subjects who 
have special medical conditions (e.g., extended dermati-
tis, urticaria in the active phase, cutaneous anergy, recent 
intake of interfering medication such as antihistamines) 
that contraindicate the conduction of skin tests [26,27].
MATERIAL AND METHODS
Seven hundred twenty-three subjects attending their 2-ye-
arly occupational health visit according to legislative 
decree  81  [28]  (i.e.,  year  3  and  6 medical  students,  and 
year 1 and 3 nursing students) and having had occu-
pational exposure to latex for less than 5 years through 
the regular use of latex gloves (i.e., at least once or twice 
a week) were invited to participate in a baseline screening 
in accordance with the guidelines for health monitoring 
established by the occupational physician. We obtained 
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indicated a possible allergy to latex, the most common 
symptoms were contact dermatitis (N = 18, 72%), contact 
urticaria (N = 3, 12%), generalized urticaria (N = 1, 4%), 
rhinitis  (N =  6;  24%)  and  asthma  (N =  4,  16%).  Some 
subjects had more than 1 symptom.
In  5  (20%)  of  25  subjects,  neither  ICAP  nor  SPT  re-
vealed sensitization to latex. In this group, symptoms 
reported  in  the  questionnaire  were  predominantly  of 
the eye and respiratory type (N = 4, 80%). In the oth-
er 20 subjects, 18 (90%) were positive upon SPT, where-
as  12  (60%)  were  found  with  sIgE  against  recombi-
nant latex allergens (ImmunoCAP k82: 1.1–17.9 kU/l). 
In 12 subjects, the highest prevalence was observed 
for  rHev  b  6.01  sIgE  (N  =  9,  67%),  followed  by 
rHev b 8 (N = 7, 58%) and rHev b 5 (N = 5, 42%) (Fig-
ure 1). The widest range was found for rHev b 6.01 sIgE 
(0.1–7.7 kU/l) (Figure 2). The ImmunoCAP k82 values 
were  higher  in  subjects  positive  to  rHev  b  6.01  sIgE 
(99.9  kU/l).  The  highest  average  of  ImmunoCAP  k82 
value was  for  rHev b 2  (13.7 kU/l). Only 2/12 subjects 
showed  a mono-sensitization,  both  to  rHev  b  5; while 
the  remaining  10/12  had multiple  sensitization.  The  2 
monosensitized  subjects were SPT-negative. We  found 






Serum obtained from subjects was tested using the Im-
munoCAP®  250  system  (fluorescence  enzyme  immuno-
assay – FEIA) in accordance with the manufacturer’s 
instructions (Phadia, Uppsala, Sweden). All sera were 
analysed for specific IgE against an NRL extract supple-
mented with rHev b 5 (Phadia Latex Recombi+k82 Im-
munoCAP®, range from 0.1 100 kU/l to > 100 kU/l), 9 Es-
cherichia coli recombinant latex allergens (rHev b 1, 
rHev b 2, rHev b 3, rHev b 5, rHev b 6.01, rHev b 6.02, 
rHev b 8, rHev b 9, rHev b 11 ImmunoCAP®). Specific im-
munoglobulin E (sIgE) values > 0.10 kU/l were considered 
positive  [34].  ImmunoCAPs™  containing  HRP  (Ro400) 
and bromelain (k202) were chosen to detect cross-reactive 
carbohydrate  determinants  specific  (CCD-specific)  IgE. 
All recombinant latex allergens offered in the Immuno-
CAP platform, except rHev b 5, are produced as malt-
ose-binding protein (MBP) fusion proteins. For this rea-




line survey was 619, representing a participation rate 
of  85.6%.  A  group  of  104  (14.4%)  subjects  refused  to 
complete  the  questionnaire:  because  completion  was 
re commended but not mandatory, part of the subjects 
wished to reduce the duration of the medical examination 
by pre ferring not to fill it out.
The  study population had a mean age of  22.5±2.6  years 
and an average work seniority of 2.5±2.4 years. There were 
more women (N = 411, 66.4%) than men (N = 208, 33.6%), 
and a prevalence of medical (N = 397, 64%) over nurs-
ing (N = 222, 36%) students. Glove-related symptoms 
were present in 25 (4%) students, 19 of whom were women 


























in the allergic workers
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DISCUSSION
Natural rubber latex is a cytoplasmic exudate of the lac-
ticifer layer of trees and contains most of the cytosolic or-
ganelles and proteins found in any plant cell. However, 
chemical treatment (hydrolysis) and the addition of sub-
stances such as ammonium hydroxide, thiurams or carba-
mates cause that users are exposed to a complex mixture of 
residual chemicals and the hydrolyzed latex peptides that 
seem to be involved in type 1 allergic reactions [36,37].
Gloves made from NRL have been in use since 
the 19th century as a means of protecting patients and 
healthcare workers from contracting infectious diseases; 
the use of latex gloves has increased more than tenfold 
over  the  last  30  years  [38]. However,  the  international 
scientific  community has paid  attention  to  allergic-type 
reactions to NRL only since the beginning of the 1980s, 
despite the fact that reference to this problem started ap-
pearing over 65 years ago [39–41]. The use of latex gloves 
is a well-known occupational problem for healthcare 
workers,  and  has  been  identified  as  a  major  source  of 
occupation-related skin and respiratory allergies in these 
workers. As noted above, the prevalence of latex allergy 
in healthcare workers varies considerably, from 2–9% 
in Finland [25] to 4–7% in Belgium among hospital em-
ployees  [12],  and  from  7%  in  operating  room  staff  in 
Finland [25] to 9–10% among operating room nurses in 
was observed  for  rHev b 6.01  sIgE  (N = 9,  50%), be-
sides  the  best  correlation  between  SPT  positivity  and 
the single allergens was found for rHev b 3 (N = 2/2) and 
rHev b 6.01  sIgE  (N = 9/9).  Instead, only 33% of pa-
tients  with  values  greater  than  0.10  kU/l  for 
rHev b  2  (N = 1/3)  and  for  rHev b  9  (N = 1/3) were 
found positive upon SPT (Figure 3).
The  percentage  of  concentration  of  different  sIgE 
to recombinant latex allergens in all 12 Immuno-
CAP positive  subjects  is  shown  in Figure 4. The high-
est correlation between symptoms and type of sIgE 
was  found  for  rHev  b  6.01  sIgE  and  contact  dermati-
tis  (N =  7/18,  44%). We  did  not  find  specific  IgE  re-
sponse to the 2 CCD-reagents (HRP and bromelain) in 
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to recombinant latex allergens
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Rihs  et  al.  [49]  reported  that  the  IgE-binding  preva-
lence of the allergens in healthcare workers was 52% 
for rHev b 1 and 13–20% for rHev b 3, whereas the preva-
lence for rHev b 6.02 was 75%. In our study, ICAP con-
firmed  the  result of  the SPT  in 10/18  (55%) of  subjects. 
The  most  relevant  allergens  in  those  found  positive 
by SPT were rHev b 6.01, rHev 8 and rHev b 5 (Figure 3). 
The  combination  of  these  3  allergens  identified  92% of 
the latex-allergic subjects in our series. It is important to 
remember that a high percentage of positivity to rHev 8 
could be attributed to latex-fruit syndrome. However, in 
accordance with previous studies [50,51], Hev b 8 mono-
sensitized persons did not present with latex-specific symp-
toms upon contact with latex-containing material, whereas 
in our study rHev 8 positivity was always associated with 
positivity to rHev b 6.01 and rHev b 5.
Reactivity to HRP and bromelain was proved to be an in 
vitro-effective screening tool for differentiating true latex 
allergy  from  clinically  insignificant  elevated  specific  IgE 
to NRL [35].
In our study, however, we have not found specific IgE re-
sponse to the 2 CCD-reagents in all allergic subjects. 
These data were probably due to the low number of pa-




ative  subjects.  This  finding,  although  limited  by  the  low 




lighted a prevalence of latex allergy in 4% of healthcare 
students  exposed  to  latex  for  less  than  5  years;  this  is 
a lower incidence than that reported in the literature for 
healthcare workers [9,11,12,25]. The ICAP showed rubber 
latex allergy profile with a high frequency of rHev b 6.01, 
France  [11]  and  surgeons,  anaesthesiologists  and  radi-
ologists in Canada [9].
As far as we know, the present study is the 1st cross-sec-
tional survey of latex sensitivity among subjects with an 
occupational exposure to latex of less than 5 years. Symp-
toms related to latex-glove use were indicated in 4% of 
questionnaires and confirmed in 1.9% by ICAP. This rela-
tively low percentage could be related to the low mean 
age and work seniority of our study group. In fact, ab-
sorption of latex proteins through the skin is considered 
by some authors to be the main pathway of sensitization, 
and this event can be associated with long-term latex 
exposure [22–25].
In the 25 subjects that indicated a possible allergy to latex 
in  the questionnaire,  the  incidence of  cutaneous  symp-
toms was 88%, with contact dermatitis present alone 
in 72%. In the 5 subjects positive according to the ques-
tionnaire  but  negative  with  SPT  and  ICAP,  symptoms 
were mainly of a non-cutaneous type and, therefore, 
likely to be caused by sensitization to other allergens, 
such as pollen and food.
In recent years, the direct determination of specific IgEs 
to  allergen  subgroups  has  become  very  important  [30]. 
Among the 15 molecularly characterized NRL Hev b al-
lergens, Hev b 5 and b 6 seem to play a major role in sen-
sitizing  healthcare workers  [30,42]  and  patients with  re-
spiratory symptoms [43]. Moreover, spina bifida patients 




sensitization in healthcare workers but not in spina bi-
fida patients [48]. In particular, Yagami et al.  [30] found 
in 20 healthcare workers suspected of having latex allergy 
that  the  positive  ratios  of  serum-specific  IgE  for  latex, 
rHev b 6.01 and rHev b 6.02 were all 100%, while those 
for rHev b 5, rHev b 8 and rHev b 11 were 42.8%, 14.2% 
and 7.1%, respectively. 
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